DGAP-News: Wirecard AG repudiates false allegations
(firmenpresse) - Wirecard AG / Statement
30.03.2010 16:37
Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Munich / Grasbrunn, March 30, 2010; Wirecard AG has issued the following
statement in response to an article on allegations published on an Internet
portal last night:
On account of a criminal investigation initiated against a private
individual in the U.S., untrue and wholly unfounded allegations are being
spread concerning business practices of the Wirecard Group.
The private individual mentioned in the article was not and is not
associated in any manner whatsoever with the Wirecard Group.
Wirecard AG unequivocally and sharply repudiates any allegations giving
rise to a suspicion of money laundering.
Moreover, Wirecard AG has commissioned an international law firm of note to
safeguard its interests by taking legal action against the Internet portal
concerned and possibly other persons involved.
Wirecard AG
Iris Stöckl
Bretonischer Ring 4
D-85630 Grasbrunn/ Germany
Ph.: +49 (0) 89 4424 0424
Fax: +49 (0) 89 4424 0524
E-Mail: iris.stoeckl(at)wirecard.com
www.wirecard.com
30.03.2010 16:37 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Medienarchiv atwww.dgap-medientreff.deandwww.dgap.de---------------------------------------------------------------------------
Language: English
Company: Wirecard AG
Bretonischer Ring 4
85630 Grasbrunn b. München
Deutschland
Phone: +49 (0)89-4424 0400
Fax: +49 (0)89-4424 0500
E-mail: ir(at)wirecard.com
Internet: www.wirecard.com
ISIN: DE0007472060
WKN: 747206
Indices: TecDAX, Prime All Share, Technology All Share
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, München, Düsseldorf, Hamburg, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="Clinuvel Pharmaceuticals Ltd.: FDA allows US clinical trials of afamelanotide in EPPDatum: 30.03.2010 - 10:37 Uhr
Sprache: Deutsch
News-ID 1012206
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 396 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Wirecard AG repudiates false allegations
"
steht unter der journalistisch-redaktionellen Verantwortung von
Wirecard AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
